Shockwave Medical (SWAV) Reports In-Line Q3 EPS

Shockwave Medical (NASDAQ: SWAV) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $61.2 million.

GUIDANCE:

Shockwave Medical sees Q4 2021 revenue of $227-228 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• InspireMD (NSPR) Tops Q2 EPS by 1c
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown